F. Tas Et Al. , "Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy," TUMOR BIOLOGY , vol.35, no.8, pp.7871-7875, 2014
Tas, F. Et Al. 2014. Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy. TUMOR BIOLOGY , vol.35, no.8 , 7871-7875.
Tas, F., Karabulut, S., Bilgin, E., & Duranyildiz, D., (2014). Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy. TUMOR BIOLOGY , vol.35, no.8, 7871-7875.
Tas, Faruk Et Al. "Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy," TUMOR BIOLOGY , vol.35, no.8, 7871-7875, 2014
Tas, Faruk Et Al. "Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy." TUMOR BIOLOGY , vol.35, no.8, pp.7871-7875, 2014
Tas, F. Et Al. (2014) . "Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy." TUMOR BIOLOGY , vol.35, no.8, pp.7871-7875.
@article{article, author={Faruk TAŞ Et Al. }, title={Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy}, journal={TUMOR BIOLOGY}, year=2014, pages={7871-7875} }